iBio, Inc. Quarterly Common Stock, Shares Authorized from Q2 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
iBio, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q2 2011 to Q1 2024.
  • iBio, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 275M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 275M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 275M 0 0% Dec 31, 2023 10-Q 2024-02-09
Q3 2023 275M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 275M 0 0% Jun 30, 2023 10-Q 2024-05-13
Q1 2023 275M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 275M 0 0% Dec 31, 2022 10-Q/A 2023-05-19
Q3 2022 275M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 275M 0 0% Jun 30, 2022 10-K 2023-09-27
Q1 2022 275M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 275M 0 0% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 275M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 275M 0 0% Jun 30, 2021 10-K 2022-10-11
Q1 2021 275M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 275M 0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 275M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 275M 0 0% Jun 30, 2020 10-K 2021-09-28
Q1 2020 275M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 275M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 275M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 275M 0 0% Jun 30, 2019 10-K 2020-10-13
Q1 2019 275M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 275M 0 0% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 275M +100M +57.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 275M +100M +57.1% Jun 30, 2018 10-K 2019-08-26
Q1 2018 275M +100M +57.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 275M +100M +57.1% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 175M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 175M 0 0% Jun 30, 2017 10-K 2018-09-18
Q1 2017 175M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 175M 0 0% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 175M 0 0% Sep 30, 2016 10-Q 2017-11-09
Q2 2016 175M 0 0% Jun 30, 2016 10-K 2017-09-15
Q1 2016 175M 0 0% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 175M 0 0% Dec 31, 2015 10-Q 2016-02-22
Q3 2015 175M 0 0% Sep 30, 2015 10-Q 2016-11-18
Q2 2015 175M 0 0% Jun 30, 2015 10-K 2016-10-13
Q1 2015 175M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 175M 0 0% Dec 31, 2014 10-Q/A 2015-02-24
Q3 2014 175M +75M +75% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 175M +75M +75% Jun 30, 2014 10-K 2015-10-13
Q1 2014 175M +75M +75% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 175M +75M +75% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 100M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 100M 0 0% Jun 30, 2013 10-K 2015-10-13
Q1 2013 100M 0 0% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 100M 0 0% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 100M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 100M 0 0% Jun 30, 2012 10-K/A 2013-10-04
Q1 2012 100M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 100M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 100M Jun 30, 2011 10-K/A 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.